Continued Dexamethasone at Discharge Not Tied to Better COVID-19 Outcomes

WEDNESDAY, March 9, 2022 -- For individuals hospitalized with COVID-19, continuing treatment with dexamethasone at discharge is not associated with a reduction in 14-day all-cause readmission or mortality, according to a study published online March...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news